[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200102843T2 - Sıtma tedavisi için kombine terkip. - Google Patents

Sıtma tedavisi için kombine terkip.

Info

Publication number
TR200102843T2
TR200102843T2 TR2001/02843T TR200102843T TR200102843T2 TR 200102843 T2 TR200102843 T2 TR 200102843T2 TR 2001/02843 T TR2001/02843 T TR 2001/02843T TR 200102843 T TR200102843 T TR 200102843T TR 200102843 T2 TR200102843 T2 TR 200102843T2
Authority
TR
Turkey
Prior art keywords
combined composition
malaria treatment
treating
malaria
treatment
Prior art date
Application number
TR2001/02843T
Other languages
English (en)
Inventor
David Chulay Jeffrey
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200102843T2 publication Critical patent/TR200102843T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Plasmodium vivax'in neden oldugu sitma enfeksiyonunun tedavi edilmesi ve önlenmesi için bir hastaya atovakuon, proguanil ve primakuin terkiplerinin uygulandigi yöntemler tarif edilmektedir.
TR2001/02843T 1999-04-09 2000-04-05 Sıtma tedavisi için kombine terkip. TR200102843T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
TR200102843T2 true TR200102843T2 (tr) 2002-01-21

Family

ID=22436426

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02843T TR200102843T2 (tr) 1999-04-09 2000-04-05 Sıtma tedavisi için kombine terkip.

Country Status (24)

Country Link
US (1) US6413993B1 (tr)
EP (1) EP1171108B1 (tr)
JP (1) JP2002541196A (tr)
KR (1) KR100613805B1 (tr)
CN (1) CN1152676C (tr)
AT (1) ATE241971T1 (tr)
AU (1) AU758167B2 (tr)
BR (1) BR0009676A (tr)
CA (1) CA2369089A1 (tr)
CZ (1) CZ294903B6 (tr)
DE (1) DE60003175T2 (tr)
DK (1) DK1171108T3 (tr)
ES (1) ES2199817T3 (tr)
HK (1) HK1041638A1 (tr)
HU (1) HUP0200842A3 (tr)
IL (2) IL145609A0 (tr)
MX (1) MXPA01010125A (tr)
NO (1) NO20014806L (tr)
NZ (1) NZ514353A (tr)
PL (1) PL350987A1 (tr)
PT (1) PT1171108E (tr)
TR (1) TR200102843T2 (tr)
WO (1) WO2000061133A1 (tr)
ZA (1) ZA200108254B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
WO2009137100A2 (en) * 2008-05-09 2009-11-12 Tolmar, Inc. Proguanil to treat skin/mucosal diseases
US20110206770A1 (en) * 2008-07-25 2011-08-25 Alphapharm Pty. Ltd. Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
WO2011021230A2 (en) * 2009-08-20 2011-02-24 Ipca Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
CN108697706B (zh) * 2016-02-12 2021-07-16 花王株式会社 黑色素分解抑制剂
KR102637575B1 (ko) * 2016-10-05 2024-02-20 타이탄 파머슈티컬즈 인코퍼레이티드 버스트 방출이 감소된 약물 전달용 이식 가능한 장치
US20200155481A1 (en) * 2017-05-03 2020-05-21 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
NO20014806L (no) 2001-12-05
HUP0200842A2 (hu) 2002-07-29
HK1041638A1 (en) 2002-07-19
WO2000061133A1 (en) 2000-10-19
JP2002541196A (ja) 2002-12-03
NZ514353A (en) 2003-10-31
IL145609A0 (en) 2002-06-30
ES2199817T3 (es) 2004-03-01
DE60003175D1 (de) 2003-07-10
EP1171108A1 (en) 2002-01-16
CN1152676C (zh) 2004-06-09
AU758167B2 (en) 2003-03-20
KR100613805B1 (ko) 2006-08-18
KR20010108468A (ko) 2001-12-07
DE60003175T2 (de) 2004-04-01
ATE241971T1 (de) 2003-06-15
DK1171108T3 (da) 2003-10-06
EP1171108B1 (en) 2003-06-04
ZA200108254B (en) 2003-03-26
MXPA01010125A (es) 2002-06-04
HUP0200842A3 (en) 2006-07-28
BR0009676A (pt) 2002-09-03
CZ294903B6 (cs) 2005-04-13
CA2369089A1 (en) 2000-10-19
NO20014806D0 (no) 2001-10-03
US6413993B1 (en) 2002-07-02
PL350987A1 (en) 2003-02-24
AU4202200A (en) 2000-11-14
CZ20013646A3 (cs) 2002-06-12
IL145609A (en) 2006-04-10
PT1171108E (pt) 2003-10-31
CN1346267A (zh) 2002-04-24

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
SE0104248D0 (sv) Method of treatment
DK0998287T3 (da) Anvendelse af levobupivacain
TR200003144T2 (tr) Tiyenopirimidinler.
TR200102843T2 (tr) Sıtma tedavisi için kombine terkip.
MXPA03011306A (es) Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.
PT1265904E (pt) Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
SE0100684D0 (sv) New subject-matter
MY133881A (en) "calcilytic compounds"
AU2003217604A8 (en) Method of treating hiv infection by preventing interaction of cd4 and gp120
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
IL139064A0 (en) Intermittent claudication therapeutic drugs comprising pyrroloazepines
DK0958290T3 (da) 1,4-Dihydropyridinderivater og terapeutisk anvendelse heraf
UA36465A (uk) Спосіб ушивання глибоких і нешироких ран та голка для його здійснення
RU99122488A (ru) Способ лечения рака эндометрия
TR199900905T2 (tr) HTLV-1 enfeksiyonlarinin tedavisi için bir ilacin yapiminda PKC inhibitörlerinin kullanimi.
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
UA29280A (uk) Спосіб лікування флегмони шлунку
ECSP982749A (es) Inhibicion de la oxidacion de lipoproteinas